ImmunoPrecise Antibodies Ltd. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

ImmunoPrecise Antibodies Ltd. (HYFT) — Frequently Asked Questions

ImmunoPrecise Antibodies Ltd. (HYFT) is a publicly traded US company. Explore HYFT's stock price, financial statements, earnings history, margins and key ratios below.

What is the HYFT stock price?

HYFT trades at $1.61 (-3.01% on the day).